BiotechTube
CardioWise

CardioWise

Fayetteville, United States· Est.
cardiowiseinc.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $11.8M

Overview

CardioWise is a private, commercial-stage digital health company founded in 2013, specializing in AI-driven cardiac image analysis. Its flagship product, SQuEEZ® (Stretch Quantifier for Endocardial Engraved Zones), has received FDA 510(k) clearance and provides a comprehensive 3D strain analysis of the heart from standard CT scans. The company targets the global cardiology market with a platform designed to increase diagnostic accuracy, enable timely interventions, and reduce healthcare costs, positioning itself at the intersection of cardiovascular diagnostics and AI/machine learning.

Cardiovascular

Technology Platform

AI-powered software platform that analyzes Cardiac Computed Tomography (cCT) data to generate 3D, color-coded models of the heart for strain quantification and functional assessment.

Funding History

2
Total raised:$11.8M
Series A$10M
Seed$1.8M

Opportunities

The massive global burden of cardiovascular disease creates a sustained demand for better diagnostic tools.
The shift towards value-based care and preventative medicine incentivizes technologies that enable early, accurate, and cost-effective diagnosis.
Integration of AI into standard imaging workflows is a major trend where CardioWise is well-positioned.

Risk Factors

The company faces significant competition from both established medical imaging corporations and numerous AI startups.
Achieving widespread market adoption requires changing clinical workflows and securing favorable insurance reimbursement.
Execution risk is high as a small private company scaling commercial operations.

Competitive Landscape

CardioWise competes in the growing market of AI-based cardiac image analysis. Competitors include large imaging OEMs (GE, Siemens, Philips) with their own AI suites, and specialized software companies like HeartFlow (CT-FFR), Cleerly (AI-powered CCTA analysis), and numerous startups focusing on echocardiography or MRI analysis. Differentiation hinges on SQuEEZ's specific focus on 3D strain from CT and its patient-facing visualization.

More companies in Diagnostics & Precision Medicine →More companies in United States →